Abstract
Sildenafil is becoming increasingly popular for the treatment of pulmonary hypertension. However, there are potential concerns regarding its effects on oxygenation and systemic hemodynamics that could theoretically reduce its utility in the neonatal population. We performed a prospective cumulative dose-response study of increasing doses of i.v. sildenafil (0.4, 1, and 3 mg/kg) on hemodynamics and oxygenation in 32 anesthetized piglets, of which 17 had meconium-induced pulmonary hypertension and lung injury, and 15 did not. Sildenafil caused a reduction in mean pulmonary artery pressure and pulmonary vascular resistance (PVR) at all doses, in non–lung-injured animals. There was no difference in pulmonary hemodynamics between doses. Oxygenation index [OI = mean airway pressure (cm H2O) ∗ FiO2 ∗ 100/PaO2 (mm Hg)] did not reach critical levels at any dose. In lung-injured animals, sildenafil also reduced mean pulmonary artery pressure and PVR by 30%. Again, this effect was achieved at the lowest dose, without subsequent changes at higher doses. However, in lung-injured animals, sildenafil produced a dose-related increase in oxygenation index. Sildenafil reduced the systemic vascular resistance (SVR) at the lowest dose in lung-injured animals, but this occurred only at higher doses in non–lung-injured animals. In conclusion, sildenafil is a potent pulmonary vasodilator. However, it should be administered with caution in the presence of lung injury because of a dose-related increase in oxygenation index and concomitant systemic vasodilatation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- OI:
-
oxygenation index
- PPHN:
-
persistent pulmonary hypertension of the newborn
- PVR:
-
pulmonary vascular resistance
- SVR:
-
systemic vascular resistance
References
Geggel RL, Reid LM 1984 The structural basis of PPHN. Clin Perinatol 11: 525–549
Kinsella JP, Abman SH 1995 Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 126: 853–864
Soukka H, Rautanen M, Halkola L, Kero P, Kaapa P 1997 Meconium aspiration induces ARDS-like pulmonary response in lungs of ten-week-old pigs. Pediatr Pulmonol 23: 205–211
Corbin JD, Francis SH 1999 Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem 274: 13729–13732
Jackson G, Benjamin N, Jackson N, Allen MJ 1999 Effects of sildenafil citrate on human hemodynamics. Am J Cardiol 83: 13C–20C
Mychaskiw G, Sachdev V, Heath BJ 2001 Sildenafil (Viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device. J Clin Anesth 13: 218–220
Abrams D, Schulze-Neick I, Magee AG 2000 Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84:E4
Atz AM, Wessel DL 1999 Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91: 307–310
Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, Bohm M, Sybrecht GW 2001 Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 104: 1218–1222
Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR 2001 Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104: 424–428
Zusman RM, Morales A, Glasser DB, Osterloh IH 1999 Overall cardiovascular profile of sildenafil citrate. Am J Cardiol 83: 35C–44C
Shekerdemian LS, Ravn HB, Penny DJ 2002 Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165: 1098–1102
Shekerdemian LS, Ravn HB, Penny DJ 2004 Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome. Pediatr Res 55: 413–418
Kleinsasser A, Loeckinger A, Hoermann C, Puehringer F, Mutz N, Bartsch G, Lindner KH 2001 Sildenafil modulates hemodynamics and pulmonary gas exchange. Am J Respir Crit Care Med 163: 339–343
Phillips BG, Kato M, Pesek CA, Winnicki M, Narkiewicz K, Davison D, Somers VK 2000 Sympathetic activation by sildenafil. Circulation 102: 3068–3073
Schwemmer M, Bassenge E, Stoeter M, Hartmann B, Hess U, Fink B 2001 Potentiation of sildenafil-induced hypotension is minimal with nitrates generating a radical intermediate. J Cardiovasc Pharmacol 38: 149–155
Ichinose F, Erana-Garcia J, Hromi J, Raveh Y, Jones R, Krim L, Clark MW, Winkler JD, Bloch KD, Zapol WM 2001 Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med 29: 1000–1005
Acknowledgements
The authors thank the Department of Biostatistics, Aarhus University, Denmark, for statistical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
This research was supported with grants from the Laerdal Foundation and The University of Aarhus, Denmark.
Rights and permissions
About this article
Cite this article
Ryhammer, P., Shekerdemian, L., Penny, D. et al. Effect of Intravenous Sildenafil on Pulmonary Hemodynamics and Gas Exchange in the Presence and Absence of Acute Lung Injury in Piglets. Pediatr Res 59, 762–766 (2006). https://doi.org/10.1203/01.pdr.0000219501.58546.aa
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.pdr.0000219501.58546.aa
This article is cited by
-
Intravenous tezosentan improves gas exchange and hemodynamics in acute lung injury secondary to meconium aspiration
Intensive Care Medicine (2008)
